Long-term usage of darbepoetin alpha in non-dialysis CKD patients

Long-term usage of darbepoetin alpha in non-dialysis CKD patients - DREAM-J

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017252

Enrollment

3000

Registered

2015-04-23

Start date

2010-08-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-dialysis CKD

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Non-dialysis CKD patients who have the first time using darbepoetin alpha for renal anemia

Exclusion criteria

Exclusion criteria: Patients who are supposed to have dialysis or kidney transplant within 6-month

Design outcomes

Primary

Measure	Time frame
ADR status / incidence	—

Countries

Japan

Contacts

Public ContactSatoru Itou

Kyowa Hakko Kirin Co., Ltd. Pharmacovigilance and Quality Assurance Division Pharmacovigilance Department

Satoru.itou@kyowa-kirin.co.jp03-3282-0063

Outcome results